logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Bifendate CAS 73536-69-3

Bifendate CAS 73536-69-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 73536-69-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/P,D/A,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White Solid
CAS NO::
73536-69-3
Molecular Formula::
C20H18O10
Molecular Weight::
418.35100
EINECS NO::
NA
MDL NO::
MFCD01751431
Appearance::
White Solid
CAS NO::
73536-69-3
Molecular Formula::
C20H18O10
Molecular Weight::
418.35100
EINECS NO::
NA
MDL NO::
MFCD01751431
Bifendate CAS 73536-69-3

Product Description:

Product Name: Bifendate CAS NO: 73536-69-3


Synonyms:

dimethyl-4,4'-d-im-ethoxy-5,6,5',6'-dimethylene dicarboxybiphenyl-2,2'-dicarboxylate;

methyl7-m-ethoxy-4-(7-m-ethoxy-5-m-ethoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate;

Biphenyldicarboxylate;


Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.00%

Density: 1.39g/cm3

Boiling Point: 606.9℃ at 760 mmHg

Flash Point: 265.9℃

Refractive Index: 1.579

Vapor Pressure: 0.0±1.7 mmHg at 25℃


Safety Information:

HS Code: 2932992000


Bifendate is a synthetic intermediate of Schisandrin C and also a anti-HBV drug used in the treatment of chronic hepatitis B. It has the effect of reducing alanine aminotransferase, and the effect of reducing alanine aminotransferase in patients with elevated serum alanine aminotransferase caused by hepatitis or drugs is significant and rapid, and the adverse reaction is less and less, and the effect is better than all kinds of hepatitis drugs in common use at present. The enzyme-lowering effect of this product for Chemicalbook increased gradually with the prolongation of the treatment course. The effect was better for those with high single alanine aminotransferase. The effect of HBsAg negative patients was more obvious than positive ones. It can improve the main symptoms of hepatitis to some extent, but has no effect on hepatomegaly and splenomegaly.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.